Clinical Trial Update: A Trial of Guanfacine-er for Cannabis Use Disorder [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating guanfacine extended-release for cannabis use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Use Disorder

Drugs mentioned

• Guanfacine ER (guanfacine extended-release)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Cannabis Use | Phase 2 | Status: COMPLETED